Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-08 | Retired Executive Vice President, Research & Development and Chief Medical Officer, Becton, Dickinson and Company. Significant experience in global product development and commercialization in regulated industries. |
| 2022-04-07 | Retired Executive Vice President, Research & Development and Chief Medical Officer, Becton, Dickinson and Company. |
| 2023-04-06 | Retired Executive Vice President, Research & Development and Chief Medical Officer, Becton, Dickinson and Company. Served as Senior Advisor to the CEO at GlaxoSmithKline. |
| 2024-04-04 | Retired Executive Vice President, Research & Development and Chief Medical Officer, Becton, Dickinson and Company. |
| 2025-04-03 | Retired Executive Vice President, Research & Development and Chief Medical Officer, Becton, Dickinson and Company; significant experience in innovation, global product development and commercialization in regulated industries. |
Data sourced from SEC filings. Last updated: 2025-07-01